Table of Content

1 Brucella Abortus Vaccine Market Overview
1.1 Brucella Abortus Vaccine Product Overview
1.2 Brucella Abortus Vaccine Market Segment by Type
1.2.1 DNA Vaccines
1.2.2 Subunit Vaccines
1.2.3 Vector Vaccines
1.2.4 B. Abortus Recombinant Mutants
1.2.5 Others
1.3 Global Brucella Abortus Vaccine Market Size by Type
1.3.1 Global Brucella Abortus Vaccine Market Size Overview by Type (2018-2034)
1.3.2 Global Brucella Abortus Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Brucella Abortus Vaccine Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Brucella Abortus Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Brucella Abortus Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Brucella Abortus Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Brucella Abortus Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Brucella Abortus Vaccine Sales Breakdown by Type (2018-2024)
2 Global Brucella Abortus Vaccine Market Competition by Company
2.1 Global Top Players by Brucella Abortus Vaccine Sales (2018-2024)
2.2 Global Top Players by Brucella Abortus Vaccine Revenue (2018-2024)
2.3 Global Top Players by Brucella Abortus Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Brucella Abortus Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Brucella Abortus Vaccine Market Competitive Situation and Trends
2.5.1 Brucella Abortus Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Brucella Abortus Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Brucella Abortus Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Brucella Abortus Vaccine Market
2.8 Key Manufacturers Brucella Abortus Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Brucella Abortus Vaccine Status and Outlook by Region
3.1 Global Brucella Abortus Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Brucella Abortus Vaccine Historic Market Size by Region
3.2.1 Global Brucella Abortus Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Brucella Abortus Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Brucella Abortus Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Brucella Abortus Vaccine Forecasted Market Size by Region
3.3.1 Global Brucella Abortus Vaccine Sales in Volume by Region (2024-2034)
3.3.2 Global Brucella Abortus Vaccine Sales in Value by Region (2024-2034)
3.3.3 Global Brucella Abortus Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Brucella Abortus Vaccine by Application
4.1 Brucella Abortus Vaccine Market Segment by Application
4.1.1 Cattles
4.1.2 Sheep
4.1.3 Pigs
4.1.4 Others
4.2 Global Brucella Abortus Vaccine Market Size by Application
4.2.1 Global Brucella Abortus Vaccine Market Size Overview by Application (2018-2034)
4.2.2 Global Brucella Abortus Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Brucella Abortus Vaccine Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Brucella Abortus Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Brucella Abortus Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Brucella Abortus Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Brucella Abortus Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Brucella Abortus Vaccine Sales Breakdown by Application (2018-2024)
5 North America Brucella Abortus Vaccine by Country
5.1 North America Brucella Abortus Vaccine Historic Market Size by Country
5.1.1 North America Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Brucella Abortus Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Brucella Abortus Vaccine Sales in Value by Country (2018-2024)
5.2 North America Brucella Abortus Vaccine Forecasted Market Size by Country
5.2.1 North America Brucella Abortus Vaccine Sales in Volume by Country (2024-2034)
5.2.2 North America Brucella Abortus Vaccine Sales in Value by Country (2024-2034)
6 Europe Brucella Abortus Vaccine by Country
6.1 Europe Brucella Abortus Vaccine Historic Market Size by Country
6.1.1 Europe Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Brucella Abortus Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Brucella Abortus Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Brucella Abortus Vaccine Forecasted Market Size by Country
6.2.1 Europe Brucella Abortus Vaccine Sales in Volume by Country (2024-2034)
6.2.2 Europe Brucella Abortus Vaccine Sales in Value by Country (2024-2034)
7 Asia-Pacific Brucella Abortus Vaccine by Region
7.1 Asia-Pacific Brucella Abortus Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Brucella Abortus Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Brucella Abortus Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Brucella Abortus Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Brucella Abortus Vaccine Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Brucella Abortus Vaccine Sales in Value by Region (2024-2034)
8 Latin America Brucella Abortus Vaccine by Country
8.1 Latin America Brucella Abortus Vaccine Historic Market Size by Country
8.1.1 Latin America Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Brucella Abortus Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Brucella Abortus Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Brucella Abortus Vaccine Forecasted Market Size by Country
8.2.1 Latin America Brucella Abortus Vaccine Sales in Volume by Country (2024-2034)
8.2.2 Latin America Brucella Abortus Vaccine Sales in Value by Country (2024-2034)
9 Middle East and Africa Brucella Abortus Vaccine by Country
9.1 Middle East and Africa Brucella Abortus Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Brucella Abortus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Brucella Abortus Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Brucella Abortus Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Brucella Abortus Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Brucella Abortus Vaccine Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Brucella Abortus Vaccine Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Zoetis
10.1.1 Zoetis Company Information
10.1.2 Zoetis Introduction and Business Overview
10.1.3 Zoetis Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Zoetis Brucella Abortus Vaccine Products Offered
10.1.5 Zoetis Recent Development
10.2 CEVA
10.2.1 CEVA Company Information
10.2.2 CEVA Introduction and Business Overview
10.2.3 CEVA Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 CEVA Brucella Abortus Vaccine Products Offered
10.2.5 CEVA Recent Development
10.3 Merck Animal Health
10.3.1 Merck Animal Health Company Information
10.3.2 Merck Animal Health Introduction and Business Overview
10.3.3 Merck Animal Health Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Merck Animal Health Brucella Abortus Vaccine Products Offered
10.3.5 Merck Animal Health Recent Development
10.4 Biovet
10.4.1 Biovet Company Information
10.4.2 Biovet Introduction and Business Overview
10.4.3 Biovet Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Biovet Brucella Abortus Vaccine Products Offered
10.4.5 Biovet Recent Development
10.5 CAVAC
10.5.1 CAVAC Company Information
10.5.2 CAVAC Introduction and Business Overview
10.5.3 CAVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 CAVAC Brucella Abortus Vaccine Products Offered
10.5.5 CAVAC Recent Development
10.6 JOVAC
10.6.1 JOVAC Company Information
10.6.2 JOVAC Introduction and Business Overview
10.6.3 JOVAC Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 JOVAC Brucella Abortus Vaccine Products Offered
10.6.5 JOVAC Recent Development
10.7 Merial
10.7.1 Merial Company Information
10.7.2 Merial Introduction and Business Overview
10.7.3 Merial Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Merial Brucella Abortus Vaccine Products Offered
10.7.5 Merial Recent Development
10.8 Colorado Serum Company
10.8.1 Colorado Serum Company Company Information
10.8.2 Colorado Serum Company Introduction and Business Overview
10.8.3 Colorado Serum Company Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Colorado Serum Company Brucella Abortus Vaccine Products Offered
10.8.5 Colorado Serum Company Recent Development
10.9 VECOL
10.9.1 VECOL Company Information
10.9.2 VECOL Introduction and Business Overview
10.9.3 VECOL Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 VECOL Brucella Abortus Vaccine Products Offered
10.9.5 VECOL Recent Development
10.10 Tecnovax
10.10.1 Tecnovax Company Information
10.10.2 Tecnovax Introduction and Business Overview
10.10.3 Tecnovax Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Tecnovax Brucella Abortus Vaccine Products Offered
10.10.5 Tecnovax Recent Development
10.11 Indian Immunologicals
10.11.1 Indian Immunologicals Company Information
10.11.2 Indian Immunologicals Introduction and Business Overview
10.11.3 Indian Immunologicals Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Indian Immunologicals Brucella Abortus Vaccine Products Offered
10.11.5 Indian Immunologicals Recent Development
10.12 Vetal
10.12.1 Vetal Company Information
10.12.2 Vetal Introduction and Business Overview
10.12.3 Vetal Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Vetal Brucella Abortus Vaccine Products Offered
10.12.5 Vetal Recent Development
10.13 Dollvet
10.13.1 Dollvet Company Information
10.13.2 Dollvet Introduction and Business Overview
10.13.3 Dollvet Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Dollvet Brucella Abortus Vaccine Products Offered
10.13.5 Dollvet Recent Development
10.14 Centro Diagnostico Veterinario
10.14.1 Centro Diagnostico Veterinario Company Information
10.14.2 Centro Diagnostico Veterinario Introduction and Business Overview
10.14.3 Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Centro Diagnostico Veterinario Brucella Abortus Vaccine Products Offered
10.14.5 Centro Diagnostico Veterinario Recent Development
10.15 Onderstepoort Biological Products
10.15.1 Onderstepoort Biological Products Company Information
10.15.2 Onderstepoort Biological Products Introduction and Business Overview
10.15.3 Onderstepoort Biological Products Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Onderstepoort Biological Products Brucella Abortus Vaccine Products Offered
10.15.5 Onderstepoort Biological Products Recent Development
10.16 Institute of Animal Health and Veterinary Biologicals
10.16.1 Institute of Animal Health and Veterinary Biologicals Company Information
10.16.2 Institute of Animal Health and Veterinary Biologicals Introduction and Business Overview
10.16.3 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Products Offered
10.16.5 Institute of Animal Health and Veterinary Biologicals Recent Development
10.17 Biogenesis Bago
10.17.1 Biogenesis Bago Company Information
10.17.2 Biogenesis Bago Introduction and Business Overview
10.17.3 Biogenesis Bago Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.17.4 Biogenesis Bago Brucella Abortus Vaccine Products Offered
10.17.5 Biogenesis Bago Recent Development
10.18 Instituto Rosenbusch
10.18.1 Instituto Rosenbusch Company Information
10.18.2 Instituto Rosenbusch Introduction and Business Overview
10.18.3 Instituto Rosenbusch Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Instituto Rosenbusch Brucella Abortus Vaccine Products Offered
10.18.5 Instituto Rosenbusch Recent Development
10.19 SYVA Laboratorios
10.19.1 SYVA Laboratorios Company Information
10.19.2 SYVA Laboratorios Introduction and Business Overview
10.19.3 SYVA Laboratorios Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.19.4 SYVA Laboratorios Brucella Abortus Vaccine Products Offered
10.19.5 SYVA Laboratorios Recent Development
10.20 CZ Veterinaria
10.20.1 CZ Veterinaria Company Information
10.20.2 CZ Veterinaria Introduction and Business Overview
10.20.3 CZ Veterinaria Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.20.4 CZ Veterinaria Brucella Abortus Vaccine Products Offered
10.20.5 CZ Veterinaria Recent Development
10.21 Hester Biosciences
10.21.1 Hester Biosciences Company Information
10.21.2 Hester Biosciences Introduction and Business Overview
10.21.3 Hester Biosciences Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Hester Biosciences Brucella Abortus Vaccine Products Offered
10.21.5 Hester Biosciences Recent Development
10.22 Qilu Animal Health
10.22.1 Qilu Animal Health Company Information
10.22.2 Qilu Animal Health Introduction and Business Overview
10.22.3 Qilu Animal Health Brucella Abortus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.22.4 Qilu Animal Health Brucella Abortus Vaccine Products Offered
10.22.5 Qilu Animal Health Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Brucella Abortus Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Brucella Abortus Vaccine Industrial Chain Analysis
11.4 Brucella Abortus Vaccine Market Dynamics
11.4.1 Brucella Abortus Vaccine Industry Trends
11.4.2 Brucella Abortus Vaccine Market Drivers
11.4.3 Brucella Abortus Vaccine Market Challenges
11.4.4 Brucella Abortus Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Brucella Abortus Vaccine Distributors
12.3 Brucella Abortus Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of DNA Vaccines
Table 2. Major Company of Subunit Vaccines
Table 3. Major Company of Vector Vaccines
Table 4. Major Company of B. Abortus Recombinant Mutants
Table 5. Major Company of Others
Table 6. Global Brucella Abortus Vaccine Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 7. Global Brucella Abortus Vaccine Sales by Type (2018-2024) & (K Units)
Table 8. Global Brucella Abortus Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 9. Global Brucella Abortus Vaccine Sales by Type (2018-2024) & (US& Million)
Table 10. Global Brucella Abortus Vaccine Market Share in Value by Type (2018-2024)
Table 11. Global Brucella Abortus Vaccine Price by Type (2018-2024) & (USD/Unit)
Table 12. Global Brucella Abortus Vaccine Sales by Type (2024-2034) & (K Units)
Table 13. Global Brucella Abortus Vaccine Sales Market Share in Volume by Type (2024-2034)
Table 14. Global Brucella Abortus Vaccine Sales by Type (2024-2034) & (US$ Million)
Table 15. Global Brucella Abortus Vaccine Sales Market Share in Value by Type (2024-2034)
Table 16. Global Brucella Abortus Vaccine Price by Type (2024-2034) & (USD/Unit)
Table 17. North America Brucella Abortus Vaccine Sales by Type (2018-2024) & (K Units)
Table 18. North America Brucella Abortus Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 19. Europe Brucella Abortus Vaccine Sales (K Units) by Type (2018-2024)
Table 20. Europe Brucella Abortus Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 21. Asia-Pacific Brucella Abortus Vaccine Sales (K Units) by Type (2018-2024)
Table 22. Asia-Pacific Brucella Abortus Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 23. Latin America Brucella Abortus Vaccine Sales (K Units) by Type (2018-2024)
Table 24. Latin America Brucella Abortus Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 25. Middle East and Africa Brucella Abortus Vaccine Sales (K Units) by Type (2018-2024)
Table 26. Middle East and Africa Brucella Abortus Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 27. Global Brucella Abortus Vaccine Sales by Company (2018-2024) & (K Units)
Table 28. Global Brucella Abortus Vaccine Sales Share by Company (2018-2024)
Table 29. Global Brucella Abortus Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 30. Global Brucella Abortus Vaccine Revenue Share by Company (2018-2024)
Table 31. Global Market Brucella Abortus Vaccine Price by Company (2018-2024) & (USD/Unit)
Table 32. Global Brucella Abortus Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 33. Global Brucella Abortus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 34. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Brucella Abortus Vaccine as of 2022)
Table 35. Date of Key Manufacturers Enter into Brucella Abortus Vaccine Market
Table 36. Key Manufacturers Brucella Abortus Vaccine Product Type
Table 37. Mergers & Acquisitions, Expansion Plans
Table 38. Global Brucella Abortus Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 39. Global Brucella Abortus Vaccine Sales by Region (2018-2024) & (K Units)
Table 40. Global Brucella Abortus Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 41. Global Brucella Abortus Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 42. Global Brucella Abortus Vaccine Sales Market Share in Value by Region (2018-2024)
Table 43. Global Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2024)
Table 44. Global Brucella Abortus Vaccine Sales by Region (2024-2034) & (K Units)
Table 45. Global Brucella Abortus Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 46. Global Brucella Abortus Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 47. Global Brucella Abortus Vaccine Sales Market Share in Value by Region (2024-2034)
Table 48. Global Brucella Abortus Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2024-2034)
Table 49. Global Brucella Abortus Vaccine Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 50. Global Brucella Abortus Vaccine Sales by Application (2018-2024) & (K Units)
Table 51. Global Brucella Abortus Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 52. Global Brucella Abortus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 53. Global Brucella Abortus Vaccine Sales Market Share in Value by Application (2018-2024)
Table 54. Global Brucella Abortus Vaccine Price by Application (2018-2024) & (USD/Unit)
Table 55. Global Brucella Abortus Vaccine Sales by Application (2024-2034) & (K Units)
Table 56. Global Brucella Abortus Vaccine Sales Market Share in Volume by Application (2024-2034)
Table 57. Global Brucella Abortus Vaccine Sales by Application (2024-2034) & (US$ Million)
Table 58. Global Brucella Abortus Vaccine Sales Market Share in Value by Application (2024-2034)
Table 59. Global Brucella Abortus Vaccine Price by Application (2024-2034) & (USD/Unit)
Table 60. North America Brucella Abortus Vaccine Sales by Application (2018-2024) (K Units)
Table 61. North America Brucella Abortus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 62. Europe Brucella Abortus Vaccine Sales by Application (2018-2024) (K Units)
Table 63. Europe Brucella Abortus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 64. Asia-Pacific Brucella Abortus Vaccine Sales by Application (2018-2024) (K Units)
Table 65. Asia-Pacific Brucella Abortus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 66. Latin America Brucella Abortus Vaccine Sales by Application (2018-2024) (K Units)
Table 67. Latin America Brucella Abortus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 68. Middle East and Africa Brucella Abortus Vaccine Sales by Application (2018-2024) (K Units)
Table 69. Middle East and Africa Brucella Abortus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 70. North America Brucella Abortus Vaccine Sales by Country (2018-2024) & (K Units)
Table 71. North America Brucella Abortus Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 72. North America Brucella Abortus Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 73. North America Brucella Abortus Vaccine Sales Market Share in Value by Country (2018-2024)
Table 74. North America Brucella Abortus Vaccine Sales by Country (2024-2034) & (K Units)
Table 75. North America Brucella Abortus Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 76. North America Brucella Abortus Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 77. North America Brucella Abortus Vaccine Sales Market Share in Value by Country (2024-2034)
Table 78. Europe Brucella Abortus Vaccine Sales by Country (2018-2024) & (K Units)
Table 79. Europe Brucella Abortus Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 80. Europe Brucella Abortus Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 81. Europe Brucella Abortus Vaccine Sales Market Share in Value by Country (2018-2024)
Table 82. Europe Brucella Abortus Vaccine Sales by Country (2024-2034) & (K Units)
Table 83. Europe Brucella Abortus Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 84. Europe Brucella Abortus Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 85. Europe Brucella Abortus Vaccine Sales Market Share in Value by Country (2024-2034)
Table 86. Asia-Pacific Brucella Abortus Vaccine Sales by Region (2018-2024) & (K Units)
Table 87. Asia-Pacific Brucella Abortus Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 88. Asia-Pacific Brucella Abortus Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 89. Asia-Pacific Brucella Abortus Vaccine Sales Market Share in Value by Region (2018-2024)
Table 90. Asia-Pacific Brucella Abortus Vaccine Sales by Region (2024-2034) & (K Units)
Table 91. Asia-Pacific Brucella Abortus Vaccine Sales Market Share in Volume by Region (2024-2034)
Table 92. Asia-Pacific Brucella Abortus Vaccine Sales by Region (2024-2034) & (US$ Million)
Table 93. Asia-Pacific Brucella Abortus Vaccine Sales Market Share in Value by Region (2024-2034)
Table 94. Latin America Brucella Abortus Vaccine Sales by Country (2018-2024) & (K Units)
Table 95. Latin America Brucella Abortus Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 96. Latin America Brucella Abortus Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 97. Latin America Brucella Abortus Vaccine Sales Market Share in Value by Country (2018-2024)
Table 98. Latin America Brucella Abortus Vaccine Sales by Country (2024-2034) & (K Units)
Table 99. Latin America Brucella Abortus Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 100. Latin America Brucella Abortus Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 101. Latin America Brucella Abortus Vaccine Sales Market Share in Value by Country (2024-2034)
Table 102. Middle East and Africa Brucella Abortus Vaccine Sales by Country (2018-2024) & (K Units)
Table 103. Middle East and Africa Brucella Abortus Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 104. Middle East and Africa Brucella Abortus Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 105. Middle East and Africa Brucella Abortus Vaccine Sales Market Share in Value by Country (2018-2024)
Table 106. Middle East and Africa Brucella Abortus Vaccine Sales by Country (2024-2034) & (K Units)
Table 107. Middle East and Africa Brucella Abortus Vaccine Sales Market Share in Volume by Country (2024-2034)
Table 108. Middle East and Africa Brucella Abortus Vaccine Sales by Country (2024-2034) & (US$ Million)
Table 109. Middle East and Africa Brucella Abortus Vaccine Sales Market Share in Value by Country (2024-2034)
Table 110. Zoetis Company Information
Table 111. Zoetis Introduction and Business Overview
Table 112. Zoetis Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 113. Zoetis Brucella Abortus Vaccine Product
Table 114. Zoetis Recent Development
Table 115. CEVA Company Information
Table 116. CEVA Introduction and Business Overview
Table 117. CEVA Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 118. CEVA Brucella Abortus Vaccine Product
Table 119. CEVA Recent Development
Table 120. Merck Animal Health Company Information
Table 121. Merck Animal Health Introduction and Business Overview
Table 122. Merck Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 123. Merck Animal Health Brucella Abortus Vaccine Product
Table 124. Merck Animal Health Recent Development
Table 125. Biovet Company Information
Table 126. Biovet Introduction and Business Overview
Table 127. Biovet Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 128. Biovet Brucella Abortus Vaccine Product
Table 129. Biovet Recent Development
Table 130. CAVAC Company Information
Table 131. CAVAC Introduction and Business Overview
Table 132. CAVAC Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 133. CAVAC Brucella Abortus Vaccine Product
Table 134. CAVAC Recent Development
Table 135. JOVAC Company Information
Table 136. JOVAC Introduction and Business Overview
Table 137. JOVAC Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 138. JOVAC Brucella Abortus Vaccine Product
Table 139. JOVAC Recent Development
Table 140. Merial Company Information
Table 141. Merial Introduction and Business Overview
Table 142. Merial Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 143. Merial Brucella Abortus Vaccine Product
Table 144. Merial Recent Development
Table 145. Colorado Serum Company Company Information
Table 146. Colorado Serum Company Introduction and Business Overview
Table 147. Colorado Serum Company Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 148. Colorado Serum Company Brucella Abortus Vaccine Product
Table 149. Colorado Serum Company Recent Development
Table 150. VECOL Company Information
Table 151. VECOL Introduction and Business Overview
Table 152. VECOL Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 153. VECOL Brucella Abortus Vaccine Product
Table 154. VECOL Recent Development
Table 155. Tecnovax Company Information
Table 156. Tecnovax Introduction and Business Overview
Table 157. Tecnovax Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 158. Tecnovax Brucella Abortus Vaccine Product
Table 159. Tecnovax Recent Development
Table 160. Indian Immunologicals Company Information
Table 161. Indian Immunologicals Introduction and Business Overview
Table 162. Indian Immunologicals Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 163. Indian Immunologicals Brucella Abortus Vaccine Product
Table 164. Indian Immunologicals Recent Development
Table 165. Vetal Company Information
Table 166. Vetal Introduction and Business Overview
Table 167. Vetal Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 168. Vetal Brucella Abortus Vaccine Product
Table 169. Vetal Recent Development
Table 170. Dollvet Company Information
Table 171. Dollvet Introduction and Business Overview
Table 172. Dollvet Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 173. Dollvet Brucella Abortus Vaccine Product
Table 174. Dollvet Recent Development
Table 175. Centro Diagnostico Veterinario Company Information
Table 176. Centro Diagnostico Veterinario Introduction and Business Overview
Table 177. Centro Diagnostico Veterinario Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 178. Centro Diagnostico Veterinario Brucella Abortus Vaccine Product
Table 179. Centro Diagnostico Veterinario Recent Development
Table 180. Onderstepoort Biological Products Company Information
Table 181. Onderstepoort Biological Products Introduction and Business Overview
Table 182. Onderstepoort Biological Products Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 183. Onderstepoort Biological Products Brucella Abortus Vaccine Product
Table 184. Onderstepoort Biological Products Recent Development
Table 185. Institute of Animal Health and Veterinary Biologicals Company Information
Table 186. Institute of Animal Health and Veterinary Biologicals Introduction and Business Overview
Table 187. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 188. Institute of Animal Health and Veterinary Biologicals Brucella Abortus Vaccine Product
Table 189. Institute of Animal Health and Veterinary Biologicals Recent Development
Table 190. Biogenesis Bago Company Information
Table 191. Biogenesis Bago Introduction and Business Overview
Table 192. Biogenesis Bago Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 193. Biogenesis Bago Brucella Abortus Vaccine Product
Table 194. Biogenesis Bago Recent Development
Table 195. Instituto Rosenbusch Company Information
Table 196. Instituto Rosenbusch Introduction and Business Overview
Table 197. Instituto Rosenbusch Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 198. Instituto Rosenbusch Brucella Abortus Vaccine Product
Table 199. Instituto Rosenbusch Recent Development
Table 200. SYVA Laboratorios Company Information
Table 201. SYVA Laboratorios Introduction and Business Overview
Table 202. SYVA Laboratorios Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 203. SYVA Laboratorios Brucella Abortus Vaccine Product
Table 204. SYVA Laboratorios Recent Development
Table 205. CZ Veterinaria Company Information
Table 206. CZ Veterinaria Introduction and Business Overview
Table 207. CZ Veterinaria Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 208. CZ Veterinaria Brucella Abortus Vaccine Product
Table 209. CZ Veterinaria Recent Development
Table 210. Hester Biosciences Company Information
Table 211. Hester Biosciences Introduction and Business Overview
Table 212. Hester Biosciences Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 213. Hester Biosciences Brucella Abortus Vaccine Product
Table 214. Hester Biosciences Recent Development
Table 215. Qilu Animal Health Company Information
Table 216. Qilu Animal Health Introduction and Business Overview
Table 217. Qilu Animal Health Brucella Abortus Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2018-2024)
Table 218. Qilu Animal Health Brucella Abortus Vaccine Product
Table 219. Qilu Animal Health Recent Development
Table 220. Key Raw Materials Lists
Table 221. Raw Materials Key Suppliers Lists
Table 222. Brucella Abortus Vaccine Market Trends
Table 223. Brucella Abortus Vaccine Market Drivers
Table 224. Brucella Abortus Vaccine Market Challenges
Table 225. Brucella Abortus Vaccine Market Restraints
Table 226. Brucella Abortus Vaccine Distributors List
Table 227. Brucella Abortus Vaccine Downstream Customers
Table 228. Research Programs/Design for This Report
Table 229. Key Data Information from Secondary Sources
Table 230. Key Data Information from Primary Sources
List of Figures
Figure 1. Brucella Abortus Vaccine Product Picture
Figure 2. Global Brucella Abortus Vaccine Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Brucella Abortus Vaccine Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Brucella Abortus Vaccine Sales Status and Outlook (2018-2034) & (K Units)
Figure 5. Product Picture of DNA Vaccines
Figure 6. Global DNA Vaccines Sales YoY Growth (2018-2034) & (K Units)
Figure 7. Product Picture of Subunit Vaccines
Figure 8. Global Subunit Vaccines Sales YoY Growth (2018-2034) & (K Units)
Figure 9. Product Picture of Vector Vaccines
Figure 10. Global Vector Vaccines Sales YoY Growth (2018-2034) & (K Units)
Figure 11. Product Picture of B. Abortus Recombinant Mutants
Figure 12. Global B. Abortus Recombinant Mutants Sales YoY Growth (2018-2034) & (K Units)
Figure 13. Product Picture of Others
Figure 14. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 15. Global Brucella Abortus Vaccine Sales by Type (2018-2034) & (US$ Million)
Figure 16. Global Brucella Abortus Vaccine Sales Market Share by Type in 2022 & 2034
Figure 17. North America Brucella Abortus Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. North America Brucella Abortus Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Europe Brucella Abortus Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Europe Brucella Abortus Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Asia-Pacific Brucella Abortus Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Asia-Pacific Brucella Abortus Vaccine Sales Market Share in Value by Type in 2022
Figure 23. Latin America Brucella Abortus Vaccine Sales Market Share in Volume by Type in 2022
Figure 24. Latin America Brucella Abortus Vaccine Sales Market Share in Value by Type in 2022
Figure 25. Middle East and Africa Brucella Abortus Vaccine Sales Market Share in Volume by Type in 2022
Figure 26. Middle East and Africa Brucella Abortus Vaccine Sales Market Share in Value by Type in 2022
Figure 27. The 5 and 10 Largest Manufacturers in the World: Market Share by Brucella Abortus Vaccine Sales in 2022
Figure 28. The 5 and 10 Largest Manufacturers in the World: Market Share by Brucella Abortus Vaccine Revenue in 2022
Figure 29. Brucella Abortus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 30. Product Picture of Cattles
Figure 31. Global Cattles Sales YoY Growth (2018-2034) & (K Units)
Figure 32. Product Picture of Sheep
Figure 33. Global Sheep Sales YoY Growth (2018-2034) & (K Units)
Figure 34. Product Picture of Pigs
Figure 35. Global Pigs Sales YoY Growth (2018-2034) & (K Units)
Figure 36. Product Picture of Others
Figure 37. Global Others Sales YoY Growth (2018-2034) & (K Units)
Figure 38. Global Brucella Abortus Vaccine Sales by Application (2018-2034) & (US$ Million)
Figure 39. Global Brucella Abortus Vaccine Sales Market Share by Application in 2022 & 2034
Figure 40. North America Brucella Abortus Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. North America Brucella Abortus Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Europe Brucella Abortus Vaccine Sales Market Share in Volume by Application in 2022
Figure 43. Europe Brucella Abortus Vaccine Sales Market Share in Value by Application in 2022
Figure 44. Asia-Pacific Brucella Abortus Vaccine Sales Market Share in Volume by Application in 2022
Figure 45. Asia-Pacific Brucella Abortus Vaccine Sales Market Share in Value by Application in 2022
Figure 46. Latin America Brucella Abortus Vaccine Sales Market Share in Volume by Application in 2022
Figure 47. Latin America Brucella Abortus Vaccine Sales Market Share in Value by Application in 2022
Figure 48. Middle East and Africa Brucella Abortus Vaccine Sales Market Share in Value by Application in 2022
Figure 49. Key Raw Materials Price
Figure 50. Brucella Abortus Vaccine Manufacturing Cost Structure
Figure 51. Brucella Abortus Vaccine Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed